CSIMarket
 


Odonate Therapeutics Inc   (ODT)
Other Ticker:  
 
 

ODT's Net Income Growth by Quarter and Year

Odonate Therapeutics Inc 's Net Income results by quarter and year




ODT Net Income (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - -32.29 -84.09 -86.38
III Quarter September -14.00 -30.48 -26.63 -0.59
II Quarter June -22.02 -33.42 -0.61 -1.39
I Quarter March -33.77 -30.16 -0.50 -16.88
FY   -69.79 -126.35 -111.83 -105.24



ODT Net Income third quarter 2021 Y/Y Growth Comment
Odonate Therapeutics Inc in the third quarter 2021 recorded net loss of $ -14.00 millions.

According to the results reported in the third quarter 2021, Odonate Therapeutics Inc achieved the best Net Income growth in Major Pharmaceutical Preparations industry. While Odonate Therapeutics Inc ' s Net Income no change of % ranks overall at the positon no. in the third quarter 2021.




ODT Net Income ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Odonate Therapeutics Inc 's third quarter 2021 Net Income $ -14.00 millions ODT's Income Statement
Odonate Therapeutics Inc 's third quarter 2020 Net Income $ -30.48 millions Quarterly ODT's Income Statement
New: More ODT's historic Net Income Growth >>


ODT Net Income (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Income third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Odonate Therapeutics Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ODT's III. Quarter Q/Q Net Income Comment
Although Odonate Therapeutics Inc in the III. Quarter 2021 showed net loss of $ -14.00 millions, some analyst point out, that those numbers are improvement compare to the -22.02 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Odonate Therapeutics Inc achieved highest sequential Net Income growth. While Odonate Therapeutics Inc 's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ODT's III. Quarter Q/Q Net Income Comment
Although Odonate Therapeutics Inc in the III. Quarter 2021 admitted net loss of $ -14.00 millions, it should be said, that those numbers are improvement relative to the -22.02 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Odonate Therapeutics Inc achieved highest sequential Net Income growth. While Odonate Therapeutics Inc 's Net Income growth quarter on quarter, overall rank is .


Odonate Therapeutics Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
Cumulative Net Income 12 Months Ending $ -102.07 $ -118.55 $ -129.96 $ -126.35 $ -178.15
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment


Odonate Therapeutics Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment


Odonate Therapeutics Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
ODT's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for ODT's Competitors
Net Income Growth for Odonate Therapeutics Inc 's Suppliers
Net Income Growth for ODT's Customers

You may also want to know
ODT's Annual Growth Rates ODT's Profitability Ratios ODT's Asset Turnover Ratio ODT's Dividend Growth
ODT's Roe ODT's Valuation Ratios ODT's Financial Strength Ratios ODT's Dividend Payout Ratio
ODT's Roa ODT's Inventory Turnover Ratio ODT's Growth Rates ODT's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Sep 30 2021 within Healthcare SectorY/Y Change %Net Income for the quarter ending Sep 30 2021
Dexcom Inc -1.80%$ -1.801 millions
Select Medical Holdings Corp-4.06%$ -4.059 millions
Owens and Minor inc-4.24%$ -4.236 millions
United Therapeutics Corporation-4.96%$ -4.965 millions
Amgen Inc -6.78%$ -6.779 millions
Quidelortho Corp-7.11%$ -7.111 millions
Eli Lilly And Company-8.13%$ -8.135 millions
Abiomed Inc -8.45%$ -8.455 millions
Universal Health Services Inc -10.13%$ -10.126 millions
U S Physical Therapy Inc-10.40%$ -10.404 millions
Quest Diagnostics Inc-10.83%$ -10.829 millions
Lemaitre Vascular Inc -13.43%$ -13.430 millions
Vyne Therapeutics Inc -13.87%$ -13.875 millions
Semler Scientific Inc -14.71%$ -14.714 millions
Pro dex Inc -15.89%$ -15.889 millions
Laboratory Corporation Of America Holdings-16.47%$ -16.470 millions
Bristol myers Squibb Company-17.36%$ -17.359 millions
Electromed Inc -17.98%$ -17.984 millions
Nature s Sunshine Products inc -23.87%$ -23.867 millions
Biostax Corp-23.97%$ -23.971 millions
Co diagnostics Inc -27.05%$ -27.051 millions
Elite Pharmaceuticals Inc -27.59%$ -27.587 millions
Collegium Pharmaceutical Inc -28.71%$ -28.708 millions
Biodelivery Sciences International Inc -28.92%$ -28.925 millions
Stryker Corp-29.47%$ -29.469 millions
Cardiff Lexington Corporation-30.80%$ -30.803 millions
Hologic Inc-33.29%$ -33.293 millions
Msa Safety Incorporated-33.33%$ -33.332 millions
Steris Plc-34.32%$ -34.321 millions
Viemed Healthcare Inc -36.20%$ -36.198 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com